Chronobiol Med > Volume 5(3); 2023 > Article |
|
Conflicts of Interest
Availability of Data and Material
The datasets generated or analyzed during the study are available from the corresponding author on reasonable request.
Author Contributions
Conceptualization: Anas El-Jaziz, Said Lotfi. Data curation: Anas El-Jaziz, Said Lotfi. Formal analysis: Anas El-Jaziz, Said Lotfi. Investigation: Anas El-Jaziz, Said Lotfi. Methodology: Anas El- Jaziz, Said Lotfi. Software: Anas El-Jaziz, Said Lotfi. Visualization: Anas El-Jaziz, Said Lotfi. Writing—original draft: Anas El-Jaziz, Said Lotfi. Writing—review & editing: Anas El-Jaziz, Said Lotfi.
BR | DR |
Wilcoxon signed-rank test |
||
---|---|---|---|---|
Z | p | |||
Sleep quality (AU) | 1.13±0.89 | 1.22±0.76 | -2.21* | 0.027 |
Sleep latency (AU) | 0.92±0.92 | 0.24±0.62 | -2.71* | 0.007 |
Sleep duration (AU) | 1.14±0.45 | 0.12±0.52 | -1.26 | 0.206 |
Sleep efficiency (AU) | 1.12±0.82 | 5.86±2.95 | -1.66 | 0.098 |
Sleep disturbance (AU) | 1.34±0.87 | 0.76±0.82 | -1.67 | 0.096 |
Use sleep medicine (AU) | 1.08±0.40 | 0.50±0.93 | -0.55 | 0.581 |
Day time dysfunction (AU) | 1.04±0.49 | 0.16±0.55 | -2.33* | 0.020 |
PSQI global score (AU) | 1.42±0.91 | 6.30 ±2.07 | -0.88 | 0.378 |
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | BMI | 1 | |||||||||||||||||
2 | MEQ score | 0.142 | 1 | ||||||||||||||||
3 | PSQI BR | -0.075 | 0.190 | 1 | |||||||||||||||
4 | Subjective sleep quality | 0.091 | 0.140 | 0.822** | 1 | ||||||||||||||
5 | Sleep latency | -0.112 | 0.176 | 0.783** | 0.667** | 1 | |||||||||||||
6 | Sleep duration | -0.155 | 0.201 | 0.836** | 0.758** | 0.689** | 1 | ||||||||||||
7 | Sleep efficiency | -0.016 | -0.071 | 0.026 | -0.114 | -0.263 | -0.083 | 1 | |||||||||||
8 | Sleep disturbance | -0.039 | 0.019 | 0.050 | -0.197 | -0.150 | -0.226 | 0.225 | 1 | ||||||||||
9 | Use of sleeping medication | -0.046 | 0.015 | 0.253 | -0.122 | 0.027 | 0.029 | 0.096 | 0.303* | 1 | |||||||||
10 | Daytime dysfunction sleep | -0.002 | 0.171 | 0.822** | 0.707** | 0.708** | 0.661** | -0.339* | -0.156 | 0.172 | 1 | ||||||||
11 | PSQI DR | 0.041 | 0.066 | 0.335* | 0.123 | 0.188 | 0.070 | 0.173 | 0.321* | 0.331* | 0.213 | 1 | |||||||
12 | Subjective sleep quality | 0.282* | 0.056 | 0.620** | 0.707** | 0.546** | 0.478** | 0.106 | -0.099 | -0.210 | 0.545** | 0.236 | 1 | ||||||
13 | Sleep latency | -0.051 | 0.003 | -0.198 | -0.366** | -0.286* | -0.341* | 0.157 | 0.333* | 0.360* | -0.255 | 0.582** | -0.411** | 1 | |||||
14 | Sleep duration | -0.011 | 0.176 | 0.335* | 0.203 | 0.106 | 0.302* | 0.240 | 0.080 | 0.241 | 0.200 | 0.358* | 0.130 | 0.282* | 1 | ||||
15 | Sleep efficiency | -0.123 | 0.170 | -0.251 | -0.320* | -0.205 | -0.335* | -0.026 | 0.225 | 0.089 | -0.239 | 0.335* | -0.376** | 0.307* | -0.257 | 1 | |||
16 | Sleep disturbance | 0.016 | 0.155 | 0.270 | 0.067 | 0.128 | 0.135 | 0.049 | 0.608** | 0.321* | 0.088 | 0.540** | -0.001 | 0.294* | 0.259 | 0.140 | 1 | ||
17 | Use of sleeping medication | -0.152 | 0.101 | 0.102 | -0.192 | -0.016 | -0.040 | 0.202 | 0.183 | 0.723** | 0.019 | 0.409** | -0.295* | 0.474** | 0.385** | 0.106 | 0.236 | 1 | |
18 | Daytime dysfunction sleep | 0.167 | -0.041 | 0.509** | 0.564** | 0.468** | 0.433** | -0.179 | -0.065 | -0.233 | 0.510** | 0.361** | 0.696** | -0.294* | -0.058 | -0.268 | 0.201 | -0.323* | 1 |
19 | SAS-sv score | -0.063 | -0.292* | -0.003 | -0.026 | -0.129 | -0.087 | 0.267 | 0.105 | -0.024 | 0.069 | -0.165 | 0.095 | -0.067 | 0.076 | -0.293* | -0.046 | -0.048 | -0.069 |